Articles

Additional safety information is being added to all montelukast products to strengthen and highlight existing warnings about serious neuropsychiatric events.

TCMs sold in Australia are carefully regulated to ensure safety and quality.

Information for health professionals about medicines with safety related updates to their Product Information.

Information for health professionals about medicines with safety related updates to their Product Information.

Health professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.

We have received Australian reports of Guillain-Barré Syndrome (GBS) following Shingrix vaccination.

Information for health professionals about medicines with safety related updates to their Product Information.

Information for health professionals about medicines with safety related updates to their Product Information.

Information for health professionals about medicines with safety related updates to their Product Information.

An updated warning about the risk of sudden cardiovascular death has been added to the Product Information and Consumer Medicine Information documents for azithromycin.

Information for health professionals about medicines with safety related updates to their Product Information.

Medicines Safety Update - Information for health professionals

The Product Information (PI) documents for antidepressants have been updated with warnings about sexual dysfunction continuing in some patients, after they stop using the medicines.

Medicines Safety Update - Information for health professionals

Medicines Safety Update - Information for health professionals

Our investigation into the risk of retinal vasculitis and/or retinal occlusive vasculitis in patients being treated with faricimab (Vabysmo) found that stronger warnings regarding this risk were needed in the Product Information (PI) and Consumer Medicine Information (CMI).

Information for health professionals about medicines with safety updates to their Production Information.

Medicines Safety Update - Information for health professionals

Medicines Safety Update - Information for health professionals

Medicines Safety Update - Information for health professionals

Be alert to new warnings of romosozumab (Evenity) cardiovascular risks for patients with a history of heart attack or stroke. If you're a health professional, read our Medicine safety update.

If you're a health professional, get the latest information about medicines with safety related updates to their Product Information.  

Recent coronial inquiries have highlighted the need for health professionals to be alert to the well documented risk of overdose with baclofen.

Medicines Safety Update - Information for health professionals

Medicines Safety Update - Information for health professionals